To find the degree of control, the prevalence of complications and cardiovascular risk factors (CVRF), and the drugs treatment used for type II diabetics.
A descriptive crossover study.
Rekaldeberri Health Centre, Bilbao.
202 diabetes II patients selected at random.
Data were gathered by interviews,… (More)